Ewald Receives BJH Neville Grant Award (Links to an external site)

Gregory Ewald, MD

Greg Ewald MD, Director, Section of Heart Failure and Heart Transplantation, has received the  2026 Neville Grant Award for Clinical Excellence. Ewald and other recipients will be recognized at the upcoming BJH Medical Staff Association Semi-Annual meeting. 

Autism Acceptance – World Autism Awareness Day (Links to an external site)

April is Autism Acceptance Month, a time dedicated to promoting inclusion and support. It has been officially rebranded from awareness to acceptance to encourage community change. The month begins with World Autism Awareness Day on April 2nd, a United Nations-sanctioned day aimed at celebrating, accepting, and amplifying the voices of autistic individuals.

Deaf History Month (Links to an external site)

Each year, National Deaf History Month is celebrated to commemorate the achievements of people who are deaf and hard of hearing. In 2026, it runs from April 1 through April 30.

Steve Brody, MD, Elected to Association of American Physicians (Links to an external site)

Steve Brody, MD

The Division of Pulmonary and Critical Care Medicine proudly congratulates Steve Brody, MD, on his election to the Association of American Physicians (AAP), one of the nation’s most respected honorary medical societies. Founded in 1885, the AAP recognizes physician scientists whose work has advanced biomedical science and improved human health.

Ying Maggie Chen Awarded NIDDK R01 Grant (Links to an external site)

Ying (Maggie) Chen, MD, PhD

Ying Maggie Chen, MD, PhD, FASN, Associate Professor of Medicine in the Division of Nephrology, has been awarded a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R01 grant totaling $2.969 million for her project, “Activating Autophagy to Treat Uromodulin-Associated Genetic Chronic Kidney Disease.”

Stopping GLP-1 drugs can quickly erase cardiovascular benefits (Links to an external site)

WashU Medicine researchers found that stopping GLP-1 drugs such as semaglutide and tirzepatide — even temporarily — elevates the risk of heart attack, stroke and death compared to staying on the medication continuously.

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular benefits. However, when patients stop taking these drugs, they not only regain weight, but, according to a new study, they also incur […]

Built to meet the moment (Links to an external site)

digital graphic

In the United States and around the world, public health is under enormous strain. Entire divisions at the Centers for Disease Control and Prevention have been dismantled; the U.S. Agency for International Development (USAID) has been shuttered; science funding through the National Institutes of Health has been slashed and thousands of public health jobs cut.

Krings Published in Annals of Internal Medicine (Links to an external site)

Krings

James Krings, MD, MSCI, Assistant Professor of Medicine, was recently published in Annals of Internal Medicine. The study, “A New Approach to Reliever Therapy in Asthma: Implications of the U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline”.

Fellows Reddy and Klucher Present Challenging Infectious Disease Cases (Links to an external site)

left to right: Prashanth Reddy, MD, Darcy Wooten, MD, and Justin Klucher, MD

WashU Medicine Infectious Diseases Fellows Prashanth Reddy, MD, and Justin Klucher, MD, recently participated in the semimar “Challenging ID Case Presentation 2026.” Hosted by the Infectious Disease Society of St. Louis (IDSTL), this annual event emphasizes the importance of clinical reasoning through real-world infectious disease cases presented by regional ID fellows. 

GLP-1 medications get at the heart of addiction: study (Links to an external site)

WashU Medicine researchers find in a new study that GLP-1 use is tied to reductions in substance use disorders and serious outcomes across all types of addictive substances.

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be effective at treating and preventing substance use disorders across all major addictive substances studied, suggesting these drugs target a common biological pathway underlying addiction.

$6.4 million supports studies of cardiac muscle function in heart failure (Links to an external site)

WashU Medicine researchers have received two grants from the NIH to study the roles of troponin — a critical protein in the heart — in various forms of heart failure. (Image: Sara Moser/WashU Medicine)

Michael J. Greenberg, PhD, an associate professor of biochemistry and molecular biophysics at Washington University School of Medicine in St. Louis, has received two grants totaling almost $6.4 million to investigate the complex roles of troponin — a critical protein in the heart — in various forms of heart failure. In particular, Greenberg’s research will […]

Publication reviews 15 years of DOLF accomplishments and looks toward disease elimination (Links to an external site)

The Death to Onchocerciasis and Lymphatic Filariasis (DOLF) project at Washington University in St. Louis

The Death to Onchocerciasis and Lymphatic Filariasis (DOLF) project at Washington University in St. Louis recently celebrated 15 years of conducting clinical and translational research to test new treat­ments to support the elimination of two major neglected tropical diseases (NTDs), namely lymphatic filariasis (LF) and onchocerciasis (also known as river blindness).

Women’s History Month (Links to an external site)

""

March offers us an opportunity to celebrate Women’s History Month.  This annual event honors women’s achievements and contributions throughout history.  The theme for the 2025 Women’s History Month is “Moving Forward Together! Women Educating & Inspiring Generations,” The theme recognizes the powerful influence of women who have dedicated their lives to education, mentorship, and leadership.

Clinical considerations for thyroid dysfunction among older adults (Links to an external site)

Sina Jasim. MD, MPH, associate professor of medicine in the Division of Endocrinology, Metabolism & Lipid Research at WashU Medicine

Sina Jasim, MD, MPH, associate professor of medicine in the Division of Endocrinology, Metabolism & Lipid Research at WashU Medicine, and Maria Papaleontiou, MD, associate professor of internal medicine in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan, have published a narrative review in Thyroid®, the official journal of the American Thyroid Association. 

Nasal vaccine combats bird flu infection in rodents (Links to an external site)

Researchers at WashU Medicine have developed a nasal vaccine against the highly pathogenic H5N1 avian influenza virus, or bird flu, which has jumped from wild birds to livestock to humans. When tested in rodents, the vaccine elicited a strong immune response and prevented infections in animals exposed to H5N1.

Since it was first detected in the U.S. in 2014, H5N1 avian influenza, commonly known as bird flu, has jumped from wild birds to farm animals and then to people, causing more than 70 human cases in the U.S. since 2022, including two fatalities. The virus continues to circulate among animals, giving it the opportunity […]

Immunotherapy reduces plaque in arteries of mice (Links to an external site)

An immunotherapy reduces plaque in the arteries of mice, offering a potential new strategy to treat cardiovascular disease, according to a study led by WashU Medicine researchers. An artery from an untreated mouse (top) shows more plaque (orange) than that of a mouse treated with the antibody-based immunotherapy (bottom).

Scientists have designed an immunotherapy that reduces plaque in the arteries of mice, presenting a possible new treatment strategy against heart disease. The antibody-based therapy could complement traditional methods of managing coronary artery disease that focus on lowering cholesterol through diet or medications such as statins, according to the findings of a new study led […]

Breath carries clues to gut microbiome health (Links to an external site)

WashU Medicine and Children’s Hospital of Philadelphia researchers found that an analysis of compounds exhaled in breath can be used to infer which microbes are living in the gut, paving the way for a rapid, non-invasive breath test to monitor and diagnose gut health issues.

The human gut is home to trillions of beneficial microbes that play a crucial role in health. Disruptions in this delicate community of bacteria and viruses — called the gut microbiome — have been linked to obesity, asthma and cancer, among other illnesses. 

Ramadan (Links to an external site)

""

This year, the holy month of Ramadan is to begin on Tuesday, February 17 – Thursday, March 19, 2026. Ramadan is the ninth month of the Islamic lunar calendar and holds great significance in the Islamic faith. It is observed by Muslims worldwide as a period of fasting, prayer, self-reflection, and increased devotion to Allah.

Kirmani Receives Lifetime Achievement Award (Links to an external site)

Nigar Kirmani, MD Professor of Medicine Division of Infectious Diseases

On November 14, 2025, Nigar Kirmani, MD, professor of medicine, was honored at the Semi-Annual General Staff Meeting and presented with the BJH Medical Staff Association Lifetime Achievement Award. This award recognizes physicians at Barnes-Jewish Hospital with over 25 years of distinguished service, honoring their exceptional contributions, leadership, teaching, and patient care.

A tribute to Stuart A. Kornfeld (1936–2025) (Links to an external site)

David C. and Betty Farrell Professor of Medicine, Stuart A. Kornfeld, MD, assistant professor Wang-Sik Lee, PhD, and associate professor Balraj Doray, PhD, look over test results in the Clinical Sciences Research Building on April 10, 2019. MATT MILLER/WASHINGTON UNIVERSITY SCHOOL OF MEDICINE Half-century of research illuminates how cells work in health, disease - Kornfeld reflects on knowledge gained from longest running NCI grant - Stuart Kornfeld, MD, has led the field of glycobiology — the study of sugars bound to proteins — for decades, fueled by the same grant from the National Cancer Institute (NCI) that first supported his lab more than 50 years ago. He reflects on his career and the advances made possible by the NCI's longest running research grant.

A giant in the field of biomedical research, Stuart Arthur Kornfeld, MD (Figure 1), passed away in St. Louis on Sunday, August 17, 2025, following complications from Parkinson’s disease. Stuart was the David C. and Betty Farrell Distinguished Professor Emeritus of Medicine at Washington University School of Medicine (WUSM). His leadership roles at WUSM, where […]

WashU startups attract record-setting $1.7 billion in private-sector investment over past year (Links to an external site)

St. Louis-based biotech company Wugen, which is developing cell-based immunotherapies for hard-to-treat blood cancers, is among the WashU startups that collectively have attracted a record-setting total of $1.7 billion in private-sector investment over the past year.

Startup companies built on Washington University in St. Louis discoveries attracted a record $1.7 billion in private-sector investment over the past year, accelerating the commercialization of WashU innovations into life-changing diagnostics, therapeutics and medical devices. Among those innovations are a blood test to diagnose Alzheimer’s disease; immunotherapies to treat aggressive blood cancers; and an AI-based […]

2025 Diabetes Day Symposium Recap (Links to an external site)

Diabetes Day Symposium

In honor of World Diabetes Day, the Diabetes Research Center of the Division of Endocrinology, Metabolism and Lipid Research hosted the 2025 Diabetes Day Symposium. The event took place on Thursday, November 6, at WashU Medicine’s Eric P. Newman Education Center. The symposium brought together scientists, trainees, and clinicians to showcase research, foster collaboration, and raise awareness of cutting-edge advances in diabetes research.